Tata Chemicals Q4FY26: Consolidated Loss Widens to ₹2,116 Crore, Standalone Profit Declines
Tata Chemicals reported a consolidated net loss of ₹2,116 crore for Q4FY26, widening from ₹67 crore in Q4FY25. Standalone profit after tax decreased to ₹48 crore from ₹97 crore year-on-year. Consolidated revenue from continuing operations was ₹3,438 crore, while standalone revenue was ₹1,254 crore.
The substantial increase in consolidated losses and the decline in standalone profits are material financial events that are likely to have a significant impact on the company's stock price and investor sentiment.
The company reported a significant widening of its consolidated net loss and a decline in standalone profit for the quarter, indicating a negative financial performance.
Tata Chemicals Limited announced its audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated net loss of ₹2,116 crore for the quarter, a significant increase compared to a loss of ₹67 crore in the same period last year. Revenue from continuing operations for the consolidated entity stood at ₹3,438 crore, a slight decrease from ₹3,509 crore in the prior year's corresponding quarter.
On a standalone basis, the company reported a profit after tax of ₹48 crore for the quarter ended March 31, 2026, a decline from ₹97 crore in the corresponding quarter of the previous fiscal year. Standalone revenue from continuing operations was ₹1,254 crore, up from ₹1,219 crore in the prior year's quarter.
The Board of Directors approved these financial results at their meeting held on May 4, 2026. The results were subsequently published in Business Standard, The Free Press Journal, and Navshakti on May 5, 2026, and are also available on the company's website.
What to do with a filing like this
Tata Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tata Chemicals Limited. Read the original for the full detail.